Skip to content

Relation Between Position of the Uterus (Anteversion or Retroversion Flexion) and Degree of Cesarean Scar Niche

Relation Between Position of the Uterus (Anteversion or Retroversion Flexion) and Degree of Cesarean Scar Niche : Cross -Sectional Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06475924
Enrollment
86
Registered
2024-06-26
Start date
2023-10-15
Completion date
2024-06-30
Last updated
2024-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anteversion of Uterus, CSD, Retroflex Uterus

Keywords

Cesarean scar defefect, Isthmocele, Caesarean scar niche, Anteverted uterus, Retroverted uterus

Brief summary

This study aims to determine the association between the size of caesarean scar niche and uterine position in childbearing women. Research hypothesis: There is a relation between uterine position and degree of cesarean scar niche. Research question: Is there a relation between uterine position and degree of cesarean scar niche?

Detailed description

It has been noted that the cesarean scar defect in patients with retroflexed uteri appear to be larger than are those in patients with anteverted uteri. This study will describe the association between position of the uterus whether share in degree of cesarean scar niche or not and associated symptoms. Primary outcome: The association between the position of the uterus (Anteverted/Retroverted) and large CSD (the ratio between the depth and adjacent myometrial thickness) Secondary outcomes: The association between position of the uterus (Anteverted/Retroverted) and: * Residual myometrial thickness (RMT). * Depth, Width, Length of SCD. The association to the clinical symptoms as: * Postmenstrual spotting: more than 2 days of intermenstrual spotting, or more than 2 days of brownish discharge after the end of menstruation if bleeding duration exceeds 7 days (discharge is considered normal if bleeding duration is \< 7 days). * Abnormal uterine bleeding (AUB) as per FIGO guideline. * Pain as dysmenorrhea, chronic pelvic pain or dyspareunia. If present will be assed using Visual Analogue Scale (VAS). * Secondary infertility: inability of a couple to conceive after one year of regular, unprotected intercourse.

Interventions

DIAGNOSTIC_TESTCaesarean scar defect evlauation by ultraosund

Women will be examined in the lithotomy position with an empty bladder. The uterus will be examined in a standardized way excluding causes of abnormal uterine bleeding or pelvic pain (myoma, polyp, pelvic inflammatory disease, adenomyosis). Upon detection of the SCD, the following will be measured: In the midsagittal plane: the depth (the vertical distance between the base and apex of the defect), width (the length of the widest gap along the cervicoisthmic canal), residual myometrial thickness (RMT) overlying the defect, and the adjacent myometrial thickness fundal to the defect. In the transverse plane: the length of the defect. The uterine position will be classified as anteverted or retroverted. Clinical symptoms of the patients will be reviewed such as :Postmenstrual spotting, Abnormal uterine bleeding, Pain, Secondary infertility.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Women in childbearing age. * At least six months postpartum. * With cesarean scar niche/defect (CSD) by transvaginal ultrasound that is defined as indentation at the site in the cesarean section scar with a depth of at least 2 mm that was agreed upon in 2019 by a European task force

Exclusion criteria

* Severely Obese (Body mass index; BMI more than or equal to 35 kg/m2). * Women with abnormal uterine pathology, observed during the ultrasound examination that may have been responsible for abnormal uterine bleeding, including endometrial hyperplasia, polyps, malignancy or myomas. * Women with any cause of pelvic pain as pelvic inflammatory diseases, endometriosis or adenomyosis. * Women with history of classic upper segment cesarean section or hysterotomy. * Women with history of previous uterine scars rather than cesarean sections as myomectomy. * Women with bleeding tendency disorders, taking anticoagulants or having chronic medical conditions as liver diseases, or coagulopathies.

Design outcomes

Primary

MeasureTime frameDescription
correlation between position of the uterus and large Cesarean Scar defect (CSD)through study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), which will be correlated to the presence of Large CSD (ratio between the depth (mm) and adjacent myometrial thickness (mm) more than or equal to 0.50)

Secondary

MeasureTime frameDescription
correlation between position of uterus and Depth, Length, Width of SCDthrough study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and measure depth (mm) and width (mm) of the Cesarean scar defect, while in transverse plane of the uterus measure length (mm) of the cesarean scar defect.
correlation between position of uterus and postmenstrual spottingthrough study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates to the presence of more than or equal to 2 days of intermenstrual spotting or more than or equal to 2 days of brownish discharge after the end of menstruation if bleeding duration exceeds 7 days (discharge is considered normal if bleeding duration is less than 7 days)
correlation between position of uterus and Residual myometrial thicknessthrough study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and measuring the thickness of the myometrium over the SCD (mm)
correlation between position of uterus and Pelvic Painthrough study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates it to the presence of Dysmenorrhea, Chronic pelvic pain or dyspareunia.
correlation between position of uterus and secondary infertilitythrough study completion, up to 6 monthssecondary infertility is defined as inability of a couple to conceive after 1 year of regular, unprotected intercourse.
correlation between position of uterus and Abnormal Uterine Bleeding (AUB)through study completion, up to 6 monthsBy using transvaginal ultrasound, the uterus will be examined in a mid sagittal plane to evaluate the position of the uterus that will be described as (Anteverted: the uterus tilts forward at the cervix/ Retroverted: the uterus tilts backward at the cervix), and correlates to the presence of AUB as per Figo guideline as regards frequency (in days), duration (in days), regularity (Regular/irregular) and intermenstrual bleeding

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026